Interim Management for Pharma -Specialty Care & Rare Diseases in Germany & Austria and Switzerland
Your partner for product launches & market entry and sustainable commercial success
Our Services
Powering Pharma Growth
Executive Go-to-Market Support
Commercial Build-up (Go-to-Market)
Market Access & AMNOG
Partner selection for the dossier preparation, evidence strategy, price anchoring, Delegation Lead in the AMNOG process and GKV-SV negotiations. Act as
interface between the Headquarter and the German organisation.
Executive Interim Management
Accelerating Your Market Success
How we support You
Greenfield Setup
Launch Readiness
Market Access & Pricing
Network & Speed
Re-Launch Support
Interim Leadership
Visual process
Executive Manager for Pharma – Specialty Care & Rare Diseases in Germany & Austria and Switzerland
Peter Prokop
Executive Manager for Pharma – Specialty Care & Rare Diseases in Germany
Reference Projects

As Head of Germany for SIFI S.p.A., I led the
company's operations and commercial strategy in
a highly specialized market environment. I was
responsible for building and guiding the local
organization, driving growth, and ensuring
successful market access and execution in
ophthalmology within the German healthcare


At Eli Lilly, I was engaged to review the
performance of a key product and assess both
strategy and team effectiveness. The analysis
identified significant untapped opportunities,
leading to a clear re-focus of sales and marketing
activities and a more targeted, performance
driven approach.


In a project with Vaccentis, I worked closely
with the CEO to assess the performance and
future potential of a subsidiary. Through a
structured evaluation and development of an
improvement plan, it became clear that there
was no sustainable business opportunity,
leading to the decision to close the entity.


As Interim Business Unit Head of Specialty Care & Rare Diseases at Chiesi, I supported the establishment of the Rare Diseases business unit, including the successful integration of two products. I built the commercial framework, aligned cross-functional teams, and laid the foundation for sustainable growth in a highly specialized market segment.


As Iterim Business Unit Head at Amgen, I took over a challenged team three months prior to a key product launch. I re-aligned the organization, finalized launch preparations, and led the team to a highly successful market introduction under significant time pressure.


As Head of Germany for SIFI S.p.A., I led the
company's operations and commercial strategy in
a highly specialized market environment. I was
responsible for building and guiding the local
organization, driving growth, and ensuring
successful market access and execution in
ophthalmology within the German healthcare

Client Testimonials